Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-11-20 2020-11-20
Drug Identification Number 02297795 02297795
Brand name APO-GLICLAZIDE MR APO-GLICLAZIDE MR
Common or Proper name GLICLAZIDE GLICLAZIDE
Company Name APOTEX INC APOTEX INC
Ingredients GLICLAZIDE GLICLAZIDE
Strength(s) 30MG 30MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-26 2020-10-26
Estimated end date 2021-03-05 2021-03-05
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments